Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion

These results indicate that intravenous injection of midkine antisense ODN is a candidate for a novel therapeutic strategy against acute tubulointerstitial injury induced by I/R injury.